Veteran private-equity and corporate finance executive with experience leading mid-market buyouts, operational turnarounds and portfolio management. James V. Thompson Jr. has held senior operating and investment roles across healthcare and business services, advising capital allocators on deal sourcing, due diligence and value creation strategies. Known for sector-focused diligence and governance oversight, often active with family offices and institutional LPs.
Veteran private-equity and corporate finance executive with experience leading mid-market buyouts, operational turnarounds and portfolio management. James V. Thompson Jr. has held senior operating and investment roles across healthcare and business services, advising capital allocators on deal sourcing, due diligence and value creation strategies. Known for sector-focused diligence and governance oversight, often active with family offices and institutional LPs.
Focuses on control-oriented mid-market buyouts and operational turnarounds with a sector lens on healthcare and business services. Emphasizes hands-on governance, rigorous sector-focused due diligence, and disciplined capital allocation that prioritizes cash-flow generation and EBITDA expansion. Pursues 3–7 year value-creation horizons driven by operational improvements, targeted add-on acquisitions, and selective strategic repositioning. Risk managed through conservative leverage, active board oversight, and measurable performance KPIs; partnership with family offices and institutional LPs to align incentives and co-invest on execution. Underwriting centers on repeatable models, margin recovery levers, and clear exit pathways to realize compounded returns from operational delta rather than multiple expansion alone.
Focuses on control-oriented mid-market buyouts and operational turnarounds with a sector lens on healthcare and business services. Emphasizes hands-on governance, rigorous sector-focused due diligence, and disciplined capital allocation that prioritizes cash-flow generation and EBITDA expansion. Pursues 3–7 year value-creation horizons driven by operational improvements, targeted add-on acquisitions, and selective strategic repositioning. Risk managed through conservative leverage, active board oversight, and measurable performance KPIs; partnership with family offices and institutional LPs to align incentives and co-invest on execution. Underwriting centers on repeatable models, margin recovery levers, and clear exit pathways to realize compounded returns from operational delta rather than multiple expansion alone.
| Trades 383 | Longs Won 253/383 66% | Profit Factor 9.3 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $261,485.06 |
| Average Win $66,600.26 | Best Trade (Oct 15) $3.58M | Sharpe Ratio -81.82 |
| Average Loss -$13,934.02 | Worst Trade (Oct 14) -$268,917.48 | Z-Score 1.68 (90.77%) |
| Commissions $0 | Avg. Trade Length 8m 4w 1d | Expectancy $39,263.91 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 13,699 | 12,329 | 10,959 | 9,589 | 8,219 | 6,849 | 5,479 | 4,110 | 2,740 | 1,370 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 3,837 | $1.01M | $1.32M | - | $305,819.16 | 30.3% | -0.061% |
AMZN Amazon.com Inc | 85 | $18,648.15 | $21,712.4 | - | $3,064.25 | 16.43% | +0.535% |
ASML ASML Holding N.V. New York Registry Shares | 8 | $7,744.53 | $13,200.56 | - | $5,456.03 | 70.45% | +0.004% |
BSX Boston Scientific Corporation | 200 | $8,730 | $8,801 | - | $71 | 0.81% | +2.337% |
CEF Sprott Physical Gold and Silver Trust | 3,987 | $120,008.7 | $161,254.21 | - | $41,245.51 | 34.37% | +2.185% |
CGCV Capital Group Conservative Equity ETF | 85,023 | $2.5M | $2.81M | - | $312,755.21 | 12.5% | +0.504% |
CGDV Capital Group Dividend Value ETF | 99,017 | $3.95M | $4.89M | - | $942,636.92 | 23.89% | +0.478% |
CGXU Capital Group International Focus Equity ETF | 53,008 | $1.53M | $1.75M | - | $220,335.31 | 14.37% | +0.364% |
CLOA iShares AAA CLO ETF | 132,666 | $6.88M | $6.88M | - | -$3,680.46 | -0.05% | +0.01% |
COST Costco Wholesale Corporation | 25 | $24,749 | $24,586.06 | - | -$162.94 | -0.66% | +0.147% |
CRM Salesforce Inc | 53 | $10,730.29 | $13,013.62 | - | $2,283.33 | 21.28% | +4.064% |
CVX Chevron Corporation | 25 | $3,518 | $5,468.5 | - | $1,950.5 | 55.44% | -1.486% |
DEXC Dimensional Emerging Markets ex China Core Equity ETF | 6,600 | $400,143.56 | $501,435 | - | $101,291.44 | 25.31% | -1.4% |
DGRO iShares Core Dividend Growth ETF | 816 | $52,174.94 | $64,158 | - | $11,983.06 | 22.97% | +0.866% |
DGRW WisdomTree U.S. Quality Dividend Growth Fund | 9,572 | $801,559.37 | $953,562.64 | - | $152,003.27 | 18.96% | +0.687% |
DLUX DoubleLine Ultrashort Income ETF | 29,261 | $1.46M | $1.46M | - | $292.95 | 0.02% | +0.12% |
EMXC iShares MSCI Emerging Markets ex China ETF | 8,454 | $623,266.36 | $794,633.73 | - | $171,367.37 | 27.5% | -1.172% |
ENFR Alerian Energy Infrastructure ETF | 8,255 | $259,661.21 | $309,851.42 | - | $50,190.21 | 19.33% | -1.895% |
FFSM Fidelity Small-Mid Cap Opportunities ETF | 2,535 | $68,927 | $85,885.8 | - | $16,958.8 | 24.6% | +1.468% |
FLOT iShares Floating Rate Bond ETF | 5,042 | $257,394.14 | $256,940.32 | - | -$453.82 | -0.18% | +0.029% |